Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIb trial of oral live attenuated human rotavirus vaccine in healthy infants
2004-001175-19Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rotaviral diarrhea comparing HRV vaccine + routine childhood vaccines with Placebo + routine childhood vaccines (2 arms). Primary endpoint: Occurrence of rotavirus gastroenteritis caused by circulating wild-type rotavirus strains. Started Jun 2004; status: completed.
02
Drugs
rotavirus vaccine, live, attenuated
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2004-001175-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001175-19.